News | Latest Breaking News Stories & Headlines

The World Health Organisation has said there has been almost 16,000 cases of Ebola in west Africa

Ebola vaccine passes early safety test

An experimental Ebola vaccine made by GlaxoSmithKline has caused no serious side effects in an early trial, scientists reported in the New England Journal of Medicine.

News • 27 Nov 14

GSK planned to cut costs by £1bn per year by 2016

GSK to float HIV drug arm as part of recovery plan

GlaxoSmithKline, battered by weak US drug sales and a bribery scandal in China, is looking to float its fast-growing HIV drugs business as part of a recovery plan that includes a fresh round of cost cutting.

Business • 22 Oct 14

Philip Hampton has been chairman of Royal Bank of Scotland since 2009

RBS chairman to leave for GlaxoSmithKline

Philip Hampton, who has been chairman of Royal Bank of Scotland since 2009, is to leave the bank next year for the same role at GlaxoSmithKline.

Business • 25 Sep 14

GlaxoSmithKline fined 3 billion yuan by Chinese authorities

China fines UK drugmaker GSK $489m

China has fined British pharmaceuticals giant GlaxoSmithKline 3 billion yuan ($488.8m) for paying out bribes in what is a record penalty for China.

Business • 19 Sep 14

GlaxoSmithKline is being investigated by Chinese authorities

Investigator hired by GSK to face trial in China

A British investigator and his American wife who were hired by British drugs giant GlaxoSmithKline are to face trial in China charged with illegally obtaining and selling private information.

Business • 14 Jul 14

80% of Britons agree with animal testing for medical purposes or in good conditions

Medical bodies to open up on animal testing

Medical organisations in Britain have pledged to reveal how, when and why animals are used in scientific tests.

News • 14 May 14

M&A deal volumes shot up following a flurry in the healthcare sector

Global M&A activity tops $1 trillion

The value of worldwide mergers and acquisitions announced so far this year has topped $1 trillion.

Business • 25 Apr 14

Staff at the pharmaceutical company's Chinese division are already accused of bribery offences

GSK probes alleged corruption in Iraqi division

British drugmaker GlaxoSmithKline is investigating alleged corruption by staff at its pharmaceuticals division in Iraq, the group has announced.

Business • 07 Apr 14

GlaxoSmithKline said there had been no risk to human health

GSK recalls drug after Cork inspection

The Irish Medicines Board has confirmed that a number of batches of an anti-depressant drug being recalled by GlaxoSmithKline had been placed on the Irish market.

News • 02 Apr 14

GSK to stop payments to healthcare professionals for attending medical conferences

GlaxoSmithKline overhauls sales practices

GlaxoSmithKline will stop paying doctors to promote its products at events and will remove individual sales targets for its marketing staff.

Business • 17 Dec 13

Three suppliers of a generic medicine all purchase the product from the same source as GlaxoSmithKline

Shortage of widely-used antibiotic flagged

Health professionals have been advised of the impending shortage of the antibiotic Augmentin by manufacturer GlaxoSmithKline.

News • 18 Oct 13

GlaxoSmithKline set to sell its Lucozade and Ribena brands

Suntory closing in on deal for Lucozade & Ribena

Japan's Suntory Beverage & Food is in advanced talks to buy GlaxoSmithKline's Lucozade and Ribena drinks for over £1 billion.

Business • 06 Sep 13

GSK's Abbas Hussain some senior employees had acted outside of the firm's "processes and controls"

GSK says some execs may have broken Chinese law

Drugs giant GlaxoSmithKline has admitted that certain top executives appeared to have broken Chinese law, as the company faces an investigation over bribery allegations there.

Business • 22 Jul 13

GSK is accused of bribing officials through travel agencies

GSK accused of bribing Chinese officials

Chinese police have accused drugmaker GlaxoSmithKline of channelling bribes to Chinese officials and doctors to boost sales illegally and raise the price of its medicines in the country.

Business • 15 Jul 13

GSK Q1 net profit dropped from £1.3 billion sterling to £961m

GSK reforms on track as Q1 profit falls 26%

Pharmaceutical company GlaxoSmithKline has reported a 26% drop in profits in the first quarter compared to a year ago.

Business • 24 Apr 13

GlaxoSmithKline's fourth quarter profits down almost 35%

Europe dents Glaxo's quarterly profits

UK pharmaceutical company GlaxoSmithKline is looking to cut costs further this year as it reported a sharp drop in fourth-quarter profit on the back of problems in Europe.

Business • 06 Feb 13

GlaxoSmithKline Q3 profit down on Europe and US

Pharmaceutical company GlaxoSmithKline says net profit was 18% lower in the third quarter as sales fell in Europe and the United States.

Business • 31 Oct 12

120 jobs saved at Stiefel Laboratories in Sligo

The GlaxoSmithKline owned Stiefel Laboratories in Sligo is to stay open.

Business • 15 Oct 12

GSK sells Australian drugs to Aspen

GlaxoSmithKline advanced its clear-out of non-core drugs today with a deal to sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare for £172m sterling.

Business • 15 Aug 12

GSK completes acquisition of Human Genome Sciences

Britain's GlaxoSmithKline PLC says it has completed its $3.6 billion acquisition of US biotech company Human Genome Sciences.

Business • 03 Aug 12

Revenue fell nearly 4% to £6.46 billion, 3% below consensus

GlaxoSmithKline Q2 net profit up but sales drop

Pharmaceutical company GlaxoSmithKline has reported a 13% gain in net profit in its second quarter compared with a year ago, but sales and earnings fell short of analysts' expectations.

Business • 25 Jul 12

GSK has agreed to be monitored by US government officials for five years

GlaxoSmithKline fined $3bn in US fraud settlement

GlaxoSmithKline is to pay $3bn in fines, in what is the largest healthcare fraud settlement in US history.

News • 03 Jul 12

GSK accused of making unbacked claims for its diabetes drug Avandia

GlaxoSmithKline fined $3 billion in US

GlaxoSmithKline was hit with $3 billion in fines by US authorities today.

Business • 02 Jul 12

GlaxoSmithKline profits fall 13% in first quarter

British drugsmaker GlaxoSmithKline said today that its net profits dropped 13% to £1.325 billion in the first quarter of 2012.

Business • 25 Apr 12

Glaxosmithkline